FOXYGEN (0667.730.875): financials and annual accounts

FOXYGEN

Wommelgem ·KBO/BCE: BE 0667.730.875

Line	2025	2024	2023	2022	2021	2020	2019	2018	2017
Balance sheet: assets
Total assets`20/58`	90,349	148,008	135,511	97,384	84,704	63,383	49,795	33,503	34,945
Fixed assets`21/28`	20,496	22,023	18,059	21,840	30,067	22,946	17,620	7,491	8,013
Tangible fixed assets`22/27`	20,496	22,023	18,059	21,840	30,067	22,946	17,620	7,491	8,013
Land and buildings`22`	-	-	-	-	-	-	9,368	2,000	2,250
Plant, machinery and equipment`23`	3,372	2,345	3,626	5,603	7,580	2,252	3,112	491	655
Furniture and vehicles`24`	9,583	12,376	5,426	5,525	10,069	6,572	5,141	5,001	5,108
Other tangible fixed assets`26`	7,541	7,303	9,008	10,713	12,417	14,122	-	-	-
Current assets`29/58`	69,853	125,985	117,452	75,544	54,637	40,437	32,175	26,012	26,932
Amounts receivable within one year`40/41`	7,171	20,309	11,928	20,889	21,425	887	12,277	18,187	11,253
Trade receivables`40`	0	12,061	11,928	9,402	13,613	74	8,391	14,599	11,253
Other amounts receivable`41`	7,171	8,248	0	11,487	7,813	813	3,886	3,588	-
Cash at bank and in hand`54/58`	61,756	98,877	95,297	40,252	12,826	36,773	17,387	6,842	14,507
Deferred charges and accrued income`490/1`	926	6,798	10,227	14,402	20,386	2,777	2,511	983	1,172
Balance sheet: equity and liabilities
Total equity and liabilities`10/49`	90,349	148,008	135,511	97,384	84,704	63,383	49,795	33,503	34,945
Equity`10/15`	53,868	63,745	65,827	78,619	78,619	56,894	43,462	27,274	25,192
Contributions`10/11`	600	600	600	600	600	600	18,600	12,400	12,400
Issued capital`100`	-	-	-	-	-	-	18,600	18,600	18,600
Uncalled capital`101`	-	-	-	-	-	-	-	6,200	6,200
Reserves`13`	53,268	63,145	65,227	78,019	78,019	56,294	24,862	14,874	12,792
Legal reserve`130`	-	-	-	-	-	-	1,408	784	640
Tax-exempt reserves`132`	-	-	-	-	-	-	110	-	-
Distributable reserves`133`	53,268	63,145	65,227	78,019	78,019	56,294	23,343	14,091	12,152
Profit (loss) carried forward`14`	0	0	0	-	-	-	-	-	-
Amounts payable`17/49`	36,482	84,263	69,684	18,765	6,085	6,489	6,333	6,229	9,753
Amounts payable within one year`42/48`	36,482	84,263	69,684	18,765	6,085	6,489	6,333	6,229	9,753
Trade debts`44`	4,385	2,436	5,914	1,791	4,860	3,360	5,972	2,736	4,552
Suppliers`440/4`	4,385	2,436	5,914	1,791	4,860	3,360	5,972	2,736	4,552
Taxes, remuneration and social security`45`	6,014	8,320	4,133	-	-	1,390	325	2,330	4,516
Taxes`450/3`	6,014	6,470	4,133	-	-	1,390	325	2,330	4,516
Remuneration and social security`454/9`	0	1,850	-	-	-	-	-	-	-
Other amounts payable`47/48`	26,083	73,507	59,637	16,974	1,225	1,739	36	1,163	685
Income statement
Non-recurring operating income`76A`	-	-	0	1,851	-	-	-	-	-
Gross operating margin`9900`	108,302	105,494	80,209	34,864	41,046	52,571	25,722	10,875	25,361
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets`630`	8,576	8,040	7,796	8,226	7,632	4,800	5,485	3,833	3,171
Other operating charges`640/8`	611	729	575	495	631	447	540	117	144
Non-recurring operating charges`66A`	-	-	0	-	-	-	803	-	-
Operating profit (loss)`9901`	99,116	96,725	71,838	26,143	32,783	47,323	18,894	6,925	22,047
Financial income`75/76B`	827	0	1	-	1	-	-	0	0
Recurring financial income`75`	827	0	1	-	1	-	-	0	0
Financial charges`65/66B`	5,862	3,944	3,100	2,838	1,423	1,605	1,846	1,031	1,066
Recurring financial charges`65`	5,862	3,944	3,100	2,838	1,423	1,605	1,846	1,031	1,066
Profit (loss) for the period before taxes`9903`	94,081	92,781	68,739	23,305	31,361	45,719	17,048	5,894	20,981
Income taxes`67/77`	19,903	20,173	14,557	5,936	8,836	12,687	5,436	3,012	8,189
Profit (loss) for the period`9904`	74,178	72,608	54,183	17,369	22,525	33,032	11,612	2,882	12,792
Transfer from tax-exempt reserves`789`	-	-	-	-	-	110	-	-	-
Transfer to tax-exempt reserves`689`	-	-	-	-	-	-	110	-	-
Profit (loss) for the period to be appropriated`9905`	74,178	72,608	54,183	17,369	22,525	33,142	11,501	2,882	12,792
Appropriation of the result
Profit (loss) to be appropriated`9906`	74,178	72,608	54,183	17,369	22,525	33,142	11,501	2,882	12,792
Transfer from equity`791/2`	9,877	2,082	12,792	16,569	-	-	-	-	-
Transfer to equity`691/2`	-	-	0	16,569	21,725	31,542	9,877	2,082	12,792
To the legal reserve`6920`	-	-	-	-	-	-	624	144	640
To other reserves`6921`	-	-	0	16,569	21,725	31,542	9,253	1,938	12,152
Profit to be distributed`694/7`	84,055	74,690	66,975	17,369	800	1,600	1,624	800	-
Return on contributions (dividend)`694`	84,055	74,690	66,975	17,369	800	1,600	1,624	800	-
Document	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF

Financial year	Type	Filed	Reference	Document
31-12-2025	micro format	19-06-2026	2026-00177041	PDF
31-12-2024	micro format	24-06-2025	2025-00190927	PDF
31-12-2023	micro format	04-04-2024	2024-00058347	PDF
31-12-2022	micro format	29-06-2023	2023-00185435	PDF
31-12-2021	micro format	29-06-2022	2022-20115380	PDF
31-12-2020	micro format	30-06-2021	2021-29300431	PDF
31-12-2019	micro format	30-06-2020	2020-25300344	PDF
31-12-2018	micro format	26-06-2019	2019-23500127	PDF
31-12-2017	micro format	28-06-2018	2018-25800019	PDF

Line	2025	2024	2023	2022	2021	2020	2019	2018	2017
EBITDA	107,691	104,765	79,634	34,369	40,415	52,123	24,379	10,758	25,217
Cash flow	82,753	80,648	61,979	25,595	30,157	37,832	17,097	6,715	15,963
Investment in fixed assets	7,048	12,004	4,015	30,794	14,753	10,126	16,417	3,312	11,183
Change in cash	-37,121	3,580	55,045	27,427	-23,947	19,386	10,545	-7,665	-
Working capital	33,371	41,722	47,768	56,779	48,552	33,948	25,842	19,783	17,179
Solvency	59.6%	43.1%	48.6%	80.7%	92.8%	89.8%	87.3%	81.4%	72.1%
Current ratio	1.91	1.50	1.69	4.03	8.98	6.23	5.08	4.18	2.76
Debt to equity	0.68	1.32	1.06	0.24	0.08	0.11	0.15	0.23	0.39
ROE	137.7%	113.9%	82.3%	22.1%	28.7%	58.1%	26.7%	10.6%	50.8%
ROA	82.1%	49.1%	40.0%	17.8%	26.6%	52.1%	23.3%	8.6%	36.6%
Interest coverage	18.37	26.57	25.69	12.11	28.40	-	-	-	-

Item	2025	2024	2023	2022	2021
Tangible fixed assets	€7,048	€12,004	€4,015	€30,794	€14,753
Depreciation and write-downs of the year	€8,576	€8,040	€7,796	€8,226	€7,632

FOXYGEN

Annual accounts 2025

Balance sheet

Change in equityin euro

Change in cashin euro

Position in the sector

Solvency59.6%

Current ratio1.91

Return on assets82.1%

Filed annual accounts

Filings

Key figures and ratios

Investments

Insights on FOXYGEN

Next steps